Efficacy of paclitaxel, carboplatin, and bevacizumab for cervical cancer: A protocol for systematic review and meta-analysis

BACKGROUND: Cervical cancer (CC) is a very common and malignant tumor in female population. Although a variety of single medications are reported to treat this condition, they all have limited efficacy. Previous studies have reported the combination of paclitaxel, carboplatin, and bevacizumab (PCB)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Zheng, Chun-yan, Cao, Jin-hui, Luo, Shu-ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302635/
https://www.ncbi.nlm.nih.gov/pubmed/32541479
http://dx.doi.org/10.1097/MD.0000000000020558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302635/
https://www.ncbi.nlm.nih.gov/pubmed/32541479
http://dx.doi.org/10.1097/MD.0000000000020558

Ejemplares similares